» Articles » PMID: 22454520

A Novel Regulatory Mechanism Links PLCγ1 to PDK1

Overview
Journal J Cell Sci
Specialty Cell Biology
Date 2012 Mar 29
PMID 22454520
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

3-Phosphoinositide-dependent protein kinase-1 (PDK1) and phospholipase C (PLC)γ1 are two key enzymes in signal transduction that control several intracellular processes. Despite the fact that PLCγ1 has been investigated for several years, the mechanisms of activation of this enzyme are still not completely clear. Similarly, although PDK1 has been mostly investigated for its role in activation of Akt, a crucial enzyme in regulation of several cellular processes, it has become evident recently that the role of PDK1 in physiological and pathological conditions is not limited to Akt activation. Here we demonstrate that PDK1 regulates PLCγ1 activation in a mechanism involving association of the two enzymes and modulation of PLCγ1 tyrosine phosphorylation. We further show that this novel PDK1-PLCγ1 pathway is important for cancer cell invasion. The identification of a PDK1-PLCγ1 pathway reveals the existence of a previously undetected link between two of the most important enzymes in signal transduction. This is likely to have profound consequences for our understanding of several cellular functions that are dependent on phosphoinositides and controlled by PDK1 and PLCγ1.

Citing Articles

TM4SF1 is a molecular facilitator that distributes cargo proteins intracellularly in endothelial cells in support of blood vessel formation.

Lin C, Merley A, Jaminet S J Cell Commun Signal. 2024; 18(2):e12031.

PMID: 38946725 PMC: 11208120. DOI: 10.1002/ccs3.12031.


Associating bovine herpesvirus 1 envelope glycoprotein gD with activated phospho-PLC-γ1(S1248).

Liu C, Yuan W, Yang H, Ni J, Tang L, Zhao H Microbiol Spectr. 2023; :e0196323.

PMID: 37655900 PMC: 10580943. DOI: 10.1128/spectrum.01963-23.


Phosphorylation of LKB1 by PDK1 Inhibits Cell Proliferation and Organ Growth by Decreased Activation of AMPK.

Borkowsky S, Gass M, Alavizargar A, Hanewinkel J, Hallstein I, Nedvetsky P Cells. 2023; 12(5).

PMID: 36899949 PMC: 10000615. DOI: 10.3390/cells12050812.


A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in NRAS Mutant Melanoma.

Cai W, Nguyen M, Wilski N, Purwin T, Vernon M, Tiago M Cancer Res. 2022; 82(14):2625-2639.

PMID: 35657206 PMC: 9298960. DOI: 10.1158/0008-5472.CAN-21-3217.


The Landscape of PDK1 in Breast Cancer.

Wang N, Fu J, Li Z, Jiang N, Chen Y, Peng J Cancers (Basel). 2022; 14(3).

PMID: 35159078 PMC: 8834120. DOI: 10.3390/cancers14030811.


References
1.
Nagashima K, Shumway S, Sathyanarayanan S, Chen A, Dolinski B, Xu Y . Genetic and pharmacological inhibition of PDK1 in cancer cells: characterization of a selective allosteric kinase inhibitor. J Biol Chem. 2010; 286(8):6433-48. PMC: 3057779. DOI: 10.1074/jbc.M110.156463. View

2.
Nystrom M, Thomas G, Stone M, Mackenzie I, Hart I, Marshall J . Development of a quantitative method to analyse tumour cell invasion in organotypic culture. J Pathol. 2005; 205(4):468-75. DOI: 10.1002/path.1716. View

3.
Piccolo E, Innominato P, Mariggio M, Maffucci T, Iacobelli S, Falasca M . The mechanism involved in the regulation of phospholipase Cgamma1 activity in cell migration. Oncogene. 2002; 21(42):6520-9. DOI: 10.1038/sj.onc.1205821. View

4.
Kolsch V, Charest P, Firtel R . The regulation of cell motility and chemotaxis by phospholipid signaling. J Cell Sci. 2008; 121(Pt 5):551-9. PMC: 2671295. DOI: 10.1242/jcs.023333. View

5.
Pinner S, Sahai E . PDK1 regulates cancer cell motility by antagonising inhibition of ROCK1 by RhoE. Nat Cell Biol. 2008; 10(2):127-37. DOI: 10.1038/ncb1675. View